New Set of Monoclonal Antibodies to Gardnerella vaginalis Released

Laboratory products

New Set of Monoclonal Antibodies to Gardnerella vaginalis Released

03 Jul, 2019

Published over 7 years ago. See the latest and most current information on Laboratory products.

Gardnerella vaginalis is a major species present in bacterial vaginosis. It is a small gram variable, anaerobic coccobacillus. Overgrowth of this bacterium occurs due to an imbalance of normal vaginal flora which can result from prescription antibiotics. 

Microscopic evaluation often shows this bacterium associated with epithelial ‘clue cells’. Treatment with metronidazole or clindamycin is recommended.

ViroStat has just released a set of new monoclonal antibodies to Gardnerella vaginalis. These specific antibodies do not cross react with other agents including Chlamydia, Candida albicans and Neisseria gonorrhoeae. Several of the antibodies function as pairs in ELISA and lateral flow immunoassay for antigen detection.

Download the data sheets for these antibodies today or click here for further information.

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Slurry grant a fossil fuel failure?
Explore more Arrow
Petro Online
Precision by weight: The critical role of gravimetric blending in fuel certification
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow